Point-of-care Cepheid Xpert HIV-1 viral load test in rural African communities is feasible and reliable

Journal of Clinical Microbiology

Volumn 54, Issue 12, 2016, Pages 3050-3055

  Moyo, Sikhulile ^a,b   Mohammed, Terence ^a   Wirth, Kathleen E ^c   Prague, Melanie ^c   Bennett, Kara ^d   Holme, Molly Pretorius ^a,c   Mupfumi, Lucy ^a   Sebogodi, Philemon ^a   Moraka, Natasha O ^a   Boleo, Corretah ^a   Maphorisa, Comfort N ^a   Seraise, Boitumelo ^a   Gaseitsiwe, Simani ^a,c   Musonda, Rosemary M ^a,c   Van Widenfelt, Erik ^a,c   Powis, Kathleen M ^a,c,e   Gaolathe, Tendani ^a   Tchetgen, Eric J Tchetgen ^c   Makhema, Joseph M ^a,b   Essex, Max ^a,c   Lockman, Shahin ^a,c,f   Novitsky, Vladimir ^a,c   more..

^a BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Bennett Statistical Consulting Inc   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BOTSWANA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEASIBILITY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFORMED CONSENT; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; NONHUMAN; POINT OF CARE TESTING; PRIORITY JOURNAL; RAPID TEST; RELIABILITY; RURAL AREA; VIRUS LOAD; BLOOD; COMPARATIVE STUDY; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; PROCEDURES; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIROLOGY;

VIRUS RNA;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BOTSWANA; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV-1; HUMANS; POINT-OF-CARE TESTING; RNA, VIRAL; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIRAL LOAD;

EID: 84997751448     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01594-16     Document Type: Article

References (32)

1. Gaolathe T, Wirth KE, Holme MP, Makhema J, Moyo S, Chakalisa U, Yankinda EK, Lei Q, Mmalane M, Novitsky V, Okui L, van Widenfelt E, Powis KM, Khan N, Bennett K, Bussmann H, Dryden-Peterson S, Lebelonyane R, El-Halabi S, Mills LA, Marukutira T, Wang R, Tchetgen Tchetgen EJ, DeGruttola V, Essex M, Lockman S, Botswana Combination Prevention Project Study Team. 2016. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: A population-based survey. Lancet HIV 3:e221- e230. http://dx.doi.org/10.1016/S2352-3018(16)00037-0.
2. Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa, Phillips A, Shroufi A, Vojnov L, Cohn J, Roberts T, Ellman T, Bonner K, Rousseau C, Garnett G, Cambiano V, Nakagawa F, Ford D, Bansi-Matharu L, Miners A, Lundgren JD, Eaton JW, Parkes-Ratanshi R, Katz Z, Maman D, Ford N, Vitoria M, Doherty M, Dowdy D, Nichols B, Murtagh M, Wareham M, Palamountain KM, Chakanyuka Musanhu C, Stevens W, Katzenstein D, Ciaranello A, Barnabas R, Braithwaite RS, Bendavid E, Nathoo KJ, van de Vijver D, Wilson DP, Holmes C, Bershteyn A, Walker S, Raizes E, Jani I, Nelson LJ, Peeling R, Terris-Prestholt F, Murungu J, Mutasa-Apollo T, Hallett TB, Revill P. 2015. Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature 528:S68 -76. http://dx.doi.org/10.1038/nature16046.
3. Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA, Saag MS. 1998. Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. J Infect Dis 177:40-47. http: //dx.doi.org/10.1086/513823.
4. Thiébaut R, Morlat P, Jacqmin-Gadda H, Neau D, Mercie P, Dabis F, Chene G. 2000. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidemiologie du SIDA en Aquitaine (GECSA). AIDS 14:971-978.
5. Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Gunthard HF, Richman DD, Wong JK. 2001. Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA 286:171-179. http://dx.doi.org/10.1001/jama.286.2 .171.
6. WHO. 2015. Consolidated guidelines on HIV testing services. World Health Organization, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665 /179870/1/9789241508926-eng.pdf?ua-1&ua-1.
7. WHO. 2015. Guideline on when start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/186275/1 /9789241509565-eng.pdf?ua-1.
8. Bélec L, Bonn JP. 2011. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: How to do more with less. Future Microbiol 6:1251-1260. http://dx.doi.org/10.2217/fmb.11.121.
9. Ondoa P, Shamu T, Bronze M, Wellington M, Boender TS, Manting C, Steegen K, Luethy R, Rinke de Wit T. 2014. Performance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, Zimbabwe. Biomed Res Int 2014:102598. http://dx .doi.org/10.1155/2014/102598.
10. Ouma KN, Basavaraju SV, Okonji JA, Williamson J, Thomas TK, Mills LA, Nkengasong JN, Zeh C. 2013. Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas AmpliPrep/ TaqMan assay, version 2.0, in Kisumu, Kenya. J Clin Microbiol 51:1208- 1218. http://dx.doi.org/10.1128/JCM.03048-12.
11. Lecher S, Ellenberger D, Kim AA, Fonjungo PN, Agolory S, Borget MY, Broyles L, Carmona S, Chipungu G, De Cock KM, Deyde V, Downer M, Gupta S, Kaplan JE, Kiyaga C, Knight N, MacLeod W, Makumbi B, Muttai H, Mwangi C, Mwangi JW, Mwasekaga M, Ng'Ang AL, Pillay Y, Sarr A, Sawadogo S, Singer D, Stevens W, Toure CA, Nkengasong J. 2015. Scale-up of HIV viral load monitoring-seven sub-Saharan African countries. MMWR Morb Mortal Wkly Rep 64:1287-1290. http://dx.doi .org/10.15585/mmwr.mm6446a3.
12. Roberts T, Cohn J, Bonner K, Hargreaves S. 2016. Scale-up of routine viral load testing in resource-poor settings: Current and future implementation challenges. Clin Infect Dis 62:1043-1048. http://dx.doi.org/10.1093 /cid/ciw001.
13. Rutstein SE, Golin CE, Wheeler SB, Kamwendo D, Hosseinipour MC, Weinberger M, Miller WC, Biddle AK, Soko A, Mkandawire M, Mwenda R, Sarr A, Gupta S, Mataya R. 2016. On the front line of HIV virological monitoring: Barriers and facilitators from a provider perspective in resource-limited settings. AIDS Care 28:1-10. http://dx.doi.org/10 .1080/09540121.2015.1058896.
14. Cogswell HA, Ohadi E, Avila C. 2016. Viral-load point-of-care technologies to achieve an AIDS-free generation. Future Microbiol 11:5-9. http: //dx.doi.org/10.2217/fmb.15.121.
15. Maiers TJ, Gous N, Nduna M, McFall SM, Kelso DM, Fisher MJ, Palamountain KM, Scott LE, Stevens WS. 2015. An investigation of fingerstick blood collection for point-of-care HIV-1 viral load monitoring in South Africa. S Afr Med J 105:228-231. http://dx.doi.org/10.7196 /SAMJ.7799.
16. Shafiee H, Kanakasabapathy MK, Juillard F, Keser M, Sadasivam M, Yuksekkaya M, Hanhauser E, Henrich TJ, Kuritzkes DR, Kaye KM, Demirci U. 2015. Printed flexible plastic microchip for viral load measurement through quantitative detection of viruses in plasma and saliva. Sci Rep 5:9919. http://dx.doi.org/10.1038/srep09919.
17. Lee HH, Dineva MA, Chua YL, Ritchie AV, Ushiro-Lumb I, Wisniewski CA. 2010. Simple amplification-based assay: A nucleic acid-based pointof-care platform for HIV-1 testing. J Infect Dis 201(Suppl 1):S65-S72.
18. Jani IV, Meggi B, Vubil A, Sitoe NE, Bhatt N, Tobaiwa O, Quevedo JI, Loquiha O, Lehe JD, Vojnov L, Peter TF. 2016. Evaluation of the whole-blood Alere Q NAT point-of-care RNA assay for HIV-1 viral load monitoring in a primary health care setting in Mozambique. J Clin Microbiol 54:2104-2108. http://dx.doi.org/10.1128/JCM.00362-16.
19. Ritchie AV, Ushiro-Lumb I, Edemaga D, Joshi HA, De Ruiter A, Szumilin E, Jendrulek I, McGuire M, Goel N, Sharma PI, Allain JP, Lee HH. 2014. SAMBA HIV semiquantitative test, a new point-of-care viralload-monitoring assay for resource-limited settings. J Clin Microbiol 52: 3377-3383. http://dx.doi.org/10.1128/JCM.00593-14.
20. Scott L, Gous N, Carmona S, Stevens W. 2015. Laboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa. J Clin Microbiol 53:1616- 1621. http://dx.doi.org/10.1128/JCM.03325-14.
21. Garrett NJ, Drain PK, Werner L, Samsunder N, Abdool Karim SS. 2016. Diagnostic accuracy of the point-of-care Xpert HIV-1 viral load assay in a South African HIV clinic. J Acquir Immune Defic Syndr 72:e45- 48. http: //dx.doi.org/10.1097/QAI.0000000000000978.
22. Ceffa S, Luhanga R, Andreotti M, Brambilla D, Erba F, Jere H, Mancinelli S, Giuliano M, Palombi L, Marazzi MC. 2016. Comparison of the Cepheid GeneXpert and Abbott m2000 HIV-1 real time molecular assays for monitoring HIV-1 viral load and detecting HIV-1 infection. J Virol Methods 229:35-39. http://dx.doi.org/10.1016/j.jviromet.2015.12.007.
23. Mor O, Gozlan Y, Wax M, Mileguir F, Rakovsky A, Noy B, Mendelson E, Levy I. 2015. Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx assays in comparison to the NucliSens EasyQ HIV-1 v20 assay for quantification of HIV-1 viral load. J Clin Microbiol 53:3458-3465. http://dx.doi.org/10.1128/JCM.01806-15.
24. Gueudin M, Baron A, Alessandri-Gradt E, Lemee V, Mourez T, Etienne M, Plantier JC. 2016. Performance evaluation of the new HIV-1 quantification assay, Xpert HIV-1 viral load, on a wide panel of HIV-1 variants. J Acquir Immune Defic Syndr 72:521-526. http://dx.doi.org/10.1097/QAI .0000000000001003.
25. HIV/AIDS Network Coordination. Virology quality assurance. HIV/ AIDS Network Coordination, Seattle, WA. https://www.hanc.info/labs /labresources/vqaResources/Pages/default.aspx.
26. R Core Team. 2014. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
27. Lehnert B. 2015. BlandAltmanLeh: Plots (slightly extended). R package version 0.3.1. http://cran.r-project.org/package-BlandAltmanLeh.
28. Manuilova E, Schuetzenmeister A, Model F. 2014. mcr: Method comparison regression. R package version 1.2.1. http://cran.r-project.org /package-mcr.
29. Sollis KA, Smit PW, Fiscus S, Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perrins J, Peeling RW. 2014. Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS One 9:e85869. http: //dx.doi.org/10.1371/journal.pone.0085869.
30. Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, Kuritzkes DR, Scott WA, Spector SA, Basgoz N, Fischl MA, D'Aquila RT. 1997. Monitoring plasma HIV-1 RNA levels in addition to CD4-lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med 126:929-938.
31. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA. 1996. HIV viral load markers in clinical practice. Nat Med 2:625-629. http://dx.doi .org/10.1038/nm0696-625.
32. Swenson LC, Cobb B, Geretti AM, Harrigan PR, Poljak M, Seguin-Devaux C, Verhofstede C, Wirden M, Amendola A, Boni J, Bourlet T, Huder JB, Karasi JC, Zidovec Lepej S, Lunar MM, Mukabayire O, Schuurman R, Tomazic J, Van Laethem K, Vandekerckhove L, Wensing AM, International Viral Load Assay Collaboration. 2014. Comparative performances of HIV-1 RNA load assays at low viral load levels: Results of an international collaboration. J Clin Microbiol 52:517-523. http://dx.doi .org/10.1128/JCM.02461-13.